This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Johnson & Johnson, Abiomed filed US antitrust paperwork on Nov. 7, setting up Dec. 7 waiting period expiration

( November 15, 2022, 15:58 GMT | Official Statement) -- MLex Summary: Johnson & Johnson and Abiomed filed their premerger paperwork with the antitrust authorities on Nov. 7, according to an Abiomed filing with the US Securities and Exchange Commission. The 30-day waiting period under the Hart-Scott-Rodino Act is set to expire on Dec. 7. Excerpt:...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections